Oncolys BioPharma Inc. (TYO:4588)
4,040.00
+20.00 (0.50%)
Aug 27, 2026, 11:30 AM JST
Oncolys BioPharma Employees
Oncolys BioPharma had 45 employees as of June 30, 2026. The number of employees increased by 4 or 9.76% compared to the same quarter last year.
Employees
45
Change
4
Growth
9.76%
Revenue / Employee
679.67K JPY
Profits / Employee
-48.93M JPY
Market Cap
118.35B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 45 | 4 | 9.76% |
| Mar 31, 2026 | 44 | 3 | 7.32% |
| Sep 30, 2025 | 42 | 4 | 10.53% |
| Jun 30, 2025 | 41 | 3 | 7.89% |
| Mar 31, 2025 | 41 | 3 | 7.89% |
| Dec 31, 2024 | 40 | 0 | - |
| Sep 30, 2024 | 38 | 0 | - |
| Jun 30, 2024 | 38 | -2 | -5.00% |
| Mar 31, 2024 | 38 | 1 | 2.70% |
| Dec 31, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2023 | 38 | 2 | 5.56% |
| Jun 30, 2023 | 40 | 2 | 5.26% |
| Mar 31, 2023 | 37 | 1 | 2.78% |
| Dec 31, 2022 | 38 | 2 | 5.56% |
| Sep 30, 2022 | 36 | 1 | 2.86% |
| Jun 30, 2022 | 38 | 2 | 5.56% |
| Mar 31, 2022 | 36 | -1 | -2.70% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| GNI Group | 990 |
| PeptiDream | 763 |
| Nxera Pharma | 322 |
| Japan Tissue Engineering | 200 |
| Healios K.K. | 75 |
| AnGes | 56 |
| Cuorips | 51 |
| StemRIM | 45 |